2月5日，工业和信息化部等八部门印发《中药工业高质量发展实施方案（2026—2030年）》（以下简称 《实施方案》）。 《实施方案》提出了未来五年的发展目标：到2030年，中药工业全产业链协同发展体系初步形成，重点 中药原料持续稳定供应能力进一步增强，数智化、绿色化水平明显提升，一批关键技术取得突破，产业 协同创新水平显著提高。 设置四大目标 根据工业和信息化部消费品工业司披露的解读，《实施方案》着力推进产业政策、监管政策、医保政策 和临床使用政策的有效协同；充分发挥地方政府发展中药工业的积极性，鼓励各地因地制宜先行先试； 将原料的持续稳定供应作为产业链供应链稳定的"牛鼻子"；将支持中药工业龙头企业发展壮大、不断提 高行业集中度作为重中之重。 《实施方案》重点围绕发展质量、协同体系、创新产品、数智化绿色化转型升级等方面设置了具体的任 务目标。 四是数智化、绿色化转型升级取得突破，制修订10项中药工业数智技术相关行业标准，推动建设一批数 智化创新载体和公共服务平台，支持企业开展数智化改造提升，发布20个数智化转型升级典型案例，建 设20个智能工厂、培育10个绿色工厂。 围绕主要目标，《实施方案》聚焦原料提质稳供 ...

Core Viewpoint - The article highlights the dedication and contributions of a procurement officer at Ben Cao Fang Yuan Pharmaceutical Group, emphasizing the importance of quality control and standardization in traditional Chinese medicine production. Group 1: Quality Control and Standardization - The procurement officer, Cao Linfei, has been committed to ensuring the quality of traditional Chinese medicine for 15 years, emphasizing the importance of quality in patient health and treatment outcomes [3][4]. - He has developed a standardized operation manual for the processing of traditional Chinese medicine, which has improved communication between management and production teams [5][8]. - The company has implemented a comprehensive quality control system, including a supplier evaluation system to ensure high-quality raw materials [5][6]. Group 2: Procurement and Cost Efficiency - In his role as a procurement officer, Cao has focused on sourcing high-quality medicinal materials, visiting over 60 production areas to understand the impact of local conditions on quality [6][7]. - The company employs a rigorous acceptance method for raw materials, which includes visual inspection, sensory evaluation, and laboratory testing to ensure compliance with standards [6][7]. - Cao has also integrated social responsibility into procurement practices, prioritizing products from regions in need, such as Xinjiang [7]. Group 3: Team Collaboration and Training - Cao emphasizes the importance of teamwork and knowledge sharing, having trained many new employees who have become key technical personnel within the company [8]. - He has fostered collaboration across departments, addressing challenges in production and quality control through joint efforts [8]. - The company aims to modernize and standardize traditional Chinese medicine practices, ensuring safety and efficacy for consumers [8].

每经记者｜张蕊 每经编辑｜陈柯名 魏官红 记者|张蕊 编辑|陈柯名 魏官红 杜恒峰 校对|程鹏 工业和信息化部等八部门日前联合印发《中药工业高质量发展实施方案（2026—2030年）》（以下简称《方案》）。 《方案》明确，到2030年，中药工业全产业链协同发展体系初步形成，重点中药原料持续稳定供应能力进一步增强，数智化、绿色化水平明显提升，一批 关键技术取得突破，产业协同创新水平显著提高。培育一批引领带动能力突出的中药工业领航企业，培育60个高标准中药原料生产基地。协同体系更加健 全，中药材种植加工、中药研发生产、流通服务等上下游各环节协同更加紧密，建设5个中药工业守正创新中心。 同时，创新产品持续涌现，推动一批中药创新药获批上市，新培育10个中成药大品种，推动一批医疗机构中药制剂转化为中药创新药。数智化、绿色化转 型升级取得突破，制修订10项中药工业数智技术相关行业标准，推动建设一批数智化创新载体和公共服务平台，支持企业开展数智化改造提升，发布20个 数智化转型升级典型案例，建设20个智能工厂、培育10个绿色工厂。 中药企业需构建以临床价值 事实上，近年来，中药行业在政策支持下迎来快速发展。华福证券研报显示 ...

2月5日，工业和信息化部等八部门正式对外发布《中药工业高质量发展实施方案（2026—2030年）》 （以下简称《实施方案》）。其中提出，到2030年，中药工业全产业链协同发展体系初步形成,重点中 药原料持续稳定供应能力进一步增强，数智化绿色化水平明显提升，一批关键技术取得突破，产业协同 创新水平显著提高。 同时，《实施方案》重点围绕发展质量、协同体系、创新产品、数智化绿色化转型升级等方面设置了到 2030年具体的任务目标，其中包括，培育一批引领带动能力突出的中药工业领航企业，培育60个高标准 中药原料生产基地；建设5个中药工业守正创新中心；推动一批中药创新药获批上市，新培育10个中成 药大品种，推动一批医疗机构中药制剂转化为中药创新药；制修订10项中药工业数智技术相关行业标 准，发布20个数智化转型升级典型案例，建设20个智能工厂、培育10个绿色工厂。 中医药是中华文明的瑰宝，中药工业是中医药现代化发展的重要支撑。围绕主要目标，工业和信息化部 消费品工业司介绍，《实施方案》以稳定供应、协同创新、智能制造、产品推广、服务体系构建为抓 手，统筹推进六个方面共15项任务。 同时，在实施原料提质稳供行动方面，《实施方 ...

工业和信息化部等八部门日前联合印发《中药工业高质量发展实施方案（2026—2030年）》（以下简称 《方案》）。 《方案》明确，到2030年，中药工业全产业链协同发展体系初步形成，重点中药原料持续稳定供应能力 进一步增强，数智化、绿色化水平明显提升，一批关键技术取得突破，产业协同创新水平显著提高。培 育一批引领带动能力突出的中药工业领航企业，培育60个高标准中药原料生产基地。协同体系更加健 全，中药材种植加工、中药研发生产、流通服务等上下游各环节协同更加紧密，建设5个中药工业守正 创新中心。 同时，创新产品持续涌现，推动一批中药创新药获批上市，新培育10个中成药大品种，推动一批医疗机 构中药制剂转化为中药创新药。数智化、绿色化转型升级取得突破，制修订10项中药工业数智技术相关 行业标准，推动建设一批数智化创新载体和公共服务平台，支持企业开展数智化改造提升，发布20个数 智化转型升级典型案例，建设20个智能工厂、培育10个绿色工厂。 中药企业需构建以临床价值为核心的全链条能力，方能突破同质化竞争 《方案》提出，到2030年，创新产品持续涌现，推动一批中药创新药获批上市，新培育10个中成药大品 种，推动一批医疗机 ...

Group 1: Traditional Chinese Medicine Industry - The Ministry of Industry and Information Technology and seven other departments issued a plan to promote the approval of innovative traditional Chinese medicine products by 2030, aiming for a collaborative development system across the entire industry chain [1] - The plan emphasizes enhancing the stable supply of key traditional Chinese medicine raw materials and improving digital and green levels, with breakthroughs in key technologies expected [1] - Analysts believe that the traditional Chinese medicine sector is poised for a turnaround after a period of adjustment, with expectations of improved performance in OTC traditional Chinese medicine products related to flu as inventory pressures ease [1] Group 2: Stock Performance and Predictions - A list of nine undervalued traditional Chinese medicine stocks with positive annual report forecasts has been compiled for reference [2] - Taiji Group is expected to see a net profit increase of 313%, while other companies like Te Yi Pharmaceutical and Yi Ling Pharmaceutical are also projected to have significant profit growth [2] Group 3: Market Trends and Adjustments - The Shanghai Futures Exchange announced adjustments to the price limits and margin requirements for gold and silver futures contracts, effective February 9 [2] - The price limit for gold futures is set at 17%, with varying margin requirements for different types of holdings [2] Group 4: Digital Services for Foreign Visitors - The National Internet Information Office and ten other departments issued opinions to enhance the digital services for foreign visitors, aiming for significant improvements by 2027 [4] Group 5: Solar Industry Outlook - The China Photovoltaic Industry Association predicts a slowdown in the growth rate of new solar installations in 2026, with an expected range of 180GW to 240GW, down from 315.07GW in 2025 [5] - The global market is also expected to see a decrease in new installations, with a forecast of 500GW under normal conditions for 2026 [5] Group 6: Investment Trends in Hong Kong Stocks - Southbound funds recorded a net purchase of 249.77 billion HKD, marking a six-month high, with significant investments in Tencent and the Tracker Fund of Hong Kong [6] - Analysts attribute this surge to the low valuation of Hong Kong tech stocks compared to A-shares and U.S. tech stocks, as well as the favorable conditions for liquidity in the Hong Kong market [6] Group 7: Cryptocurrency Market Decline - The cryptocurrency market experienced a significant drop, with Bitcoin prices falling below 70,000 USD, leading to a total market loss of approximately 1.3 trillion RMB [7] - The decline was triggered by comments from U.S. Treasury Secretary Scott Becerra indicating that the government would not bail out cryptocurrencies [7] Group 8: NIO's Financial Performance - NIO's stock rose over 10% after the company announced it expects to report adjusted operating profits for the fourth quarter of 2025, marking its first quarterly profit [8] Group 9: Meituan's Acquisition - Meituan announced a significant acquisition of Dingdong Maicai for 717 million USD, which will integrate Dingdong's financial performance into Meituan's reports [9] Group 10: Central Bank Interest Rates - The European Central Bank and the Bank of England maintained their interest rates, aligning with market expectations, with the ECB holding rates steady for the fifth consecutive meeting [9]

2026.02.05 本文字数：1126，阅读时长大约2分钟 作者 |第一财经 黄思瑜 春节前最后几个交易日里，近20家沪市公司将合计发放258亿元春节红包。从2025年12月起至春节前， 沪市合计发放的分红金额合计将突破3476亿元。 在业内看来，银行股在分红节奏和分红频次上的变化，成为"春节前分红"政策落地的一个直观体现，让 投资者更早、更清晰地看到现金回报，无疑是一种对于投资者持股感受的提升与优化。 除了银行业外，还有较多传统行业公司在春节前向投资者发放现金红包，包括长江电力 （600900.SH）、达仁堂（600329.SH）等在内的多家公司将在春节前最后一周内发放现金红包。 其中，长江电力将于2月12日发放2025年中期分红，合计派发超过51亿元。该公司自2016年在国内率先 做出10年期高比例现金分红承诺。根据承诺，2016年至2020年每年每股现金分红不低于0.65元；2021年 至2025年每年现金分红比例不低于当年净利润的70%。近五年，长江电力现金分红金额总计达976.90亿 元。 2月4日晚间，达仁堂也发布了2025年季度权益分派实施公告，将每股派发现金红利2.45元（含税），共 计派发 ...

Core Viewpoint - The article highlights the significant cash dividends being distributed by companies in the Shanghai stock market, particularly focusing on the banking sector, which is leading the trend of pre-Spring Festival cash distributions to investors [3][4]. Group 1: Cash Dividends Distribution - Nearly 20 companies in the Shanghai market are set to distribute a total of 25.8 billion yuan in cash dividends before the Spring Festival [3]. - From December 2025 to the pre-Spring Festival period, the total cash dividends distributed by the Shanghai market will exceed 347.6 billion yuan, with 321.8 billion yuan already distributed by February 5 [3]. - Industrial Bank is set to distribute over 11.9 billion yuan in cash dividends to A-share investors, with a per-share cash dividend of 0.565 yuan (tax included) [3]. Group 2: Banking Sector Performance - The banking sector is the main contributor to cash distributions, with nine banks, including Industrial Bank, Jiangsu Bank, and China Merchants Bank, announcing a total of nearly 70 billion yuan in cash dividends for the first half of 2025 [3][4]. - China Merchants Bank announced a cash dividend of approximately 25.5 billion yuan (tax included) for A+H shares, with a distribution ratio of 35% [3]. Group 3: Other Industries - Other traditional industries are also participating in cash distributions, with companies like Yangtze Power and Da Ren Tang planning to issue cash dividends before the Spring Festival [4]. - Yangtze Power will distribute over 5.1 billion yuan in cash dividends on February 12, having committed to a high cash dividend ratio since 2016 [4]. - Da Ren Tang announced a cash dividend of 2.45 yuan per share (tax included), totaling 1.887 billion yuan, with a cumulative cash dividend of 5.117 billion yuan since its listing [5]. Group 4: Regulatory Environment and Investor Sentiment - Industry insiders note that the continuous strengthening of cash dividend regulations and disclosure requirements by regulatory authorities is enhancing shareholder return awareness among listed companies [6]. - Investors are increasingly inclined to choose companies that can withstand economic cycles and are willing to consistently return value to shareholders, marking a significant trend in value investing [6].

明日主题前瞻 1、中药 | 工信部等八部门印发《中药工业高质量发展实施方案（2026—2030年）》。方案提出，到2030年，中药工业全产业链协同发展体系初步形成，重 点中药原料持续稳定供应能力进一步增强，数智化、绿色化水平明显提升，一批关键技术取得突破，产业协同创新水平显著提高。发展质量明显提高，培育 一批引领带动能力突出的中药工业领航企业，培育60个高标准中药原料生产基地。协同体系更加健全，建设5个中药工业守正创新中心。创新产品持续涌 现，推动一批中药创新药获批上市，新培育10个中成药大品种，推动一批医疗机构中药制剂转化为中药创新药。 点评：分析认为，我国中药产业规模已突破1.2万亿元，形成涵盖种植、饮片、中成药及大健康产品的完整产业链。但行业仍面临中药材质量波动、研发投 入偏低、国际认证壁垒等挑战。目前行业整体处于由传统经验驱动向科学化、证据化跃升的关键阶段，利好政策的陆续落地将提升中药产业集约化、现代 化、国际化水平，推动从资源依赖向创新驱动转型，夯实中医药高质量发展的工业基础。机构认为，中药板块估值和机构持仓两个方面均处于历史底位，同 时基本面随着高基数效应和库存等不利因素影响减弱也逐步改善向好，部 ...

证券日报网讯2月5日，桂林三金（002275）在互动平台回答投资者提问时表示，公司主要中药品种的说 明书均已修订完善，并完成了再注册，该规定不会影响产品正常上市销售。 ...